JP1696295S - - Google Patents

Info

Publication number
JP1696295S
JP1696295S JPD2021-3980F JP2021003980F JP1696295S JP 1696295 S JP1696295 S JP 1696295S JP 2021003980 F JP2021003980 F JP 2021003980F JP 1696295 S JP1696295 S JP 1696295S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-3980F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2021-3980F priority Critical patent/JP1696295S/ja
Priority to US29/800,873 priority patent/USD1016033S1/en
Priority to TW110304317F priority patent/TWD217038S/zh
Application granted granted Critical
Publication of JP1696295S publication Critical patent/JP1696295S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-3980F 2021-02-26 2021-02-26 Active JP1696295S (Direct)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2021-3980F JP1696295S (Direct) 2021-02-26 2021-02-26
US29/800,873 USD1016033S1 (en) 2021-02-26 2021-07-23 Servo amplifier
TW110304317F TWD217038S (zh) 2021-02-26 2021-08-18 伺服放大器之部分

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2021-3980F JP1696295S (Direct) 2021-02-26 2021-02-26

Publications (1)

Publication Number Publication Date
JP1696295S true JP1696295S (Direct) 2021-10-04

Family

ID=77915456

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2021-3980F Active JP1696295S (Direct) 2021-02-26 2021-02-26

Country Status (3)

Country Link
US (1) USD1016033S1 (Direct)
JP (1) JP1696295S (Direct)
TW (1) TWD217038S (Direct)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP1646064S (Direct) * 2019-04-25 2019-11-18
USD1038059S1 (en) * 2019-04-25 2024-08-06 Panasonic Intellectual Property Management Co., Ltd. Servo amplifier
JP1646063S (Direct) * 2019-04-25 2019-11-18
USD1076807S1 (en) * 2019-09-09 2025-05-27 Mitsubishi Electric Corporation Servo amplifier
JP1659137S (Direct) * 2019-09-09 2020-05-11
USD987594S1 (en) * 2020-04-21 2023-05-30 Mitsubishi Electric Corporation Servo amplifier
JP1714265S (ja) * 2021-10-25 2022-05-09 サーボアンプ

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD328058S (en) * 1989-09-14 1992-07-21 Mitsubishi Denki Kabushiki Kaisha Power inverter
USD337304S (en) * 1991-10-04 1993-07-13 Motorola, Inc. Electronic equipment power amplifier module
USD724052S1 (en) * 2012-11-15 2015-03-10 Mitsubishi Electric Corporation Servo amplifier
USD724051S1 (en) * 2012-11-15 2015-03-10 Mitsubishi Electric Corporation Servo amplifier
USD906960S1 (en) * 2019-01-31 2021-01-05 Mitsubishi Electric Corporation Servo amplifier
USD918857S1 (en) * 2019-01-31 2021-05-11 Mitsubishi Electric Corporation Servo amplifier
JP1647700S (Direct) * 2019-01-31 2019-12-09
JP1659136S (Direct) * 2019-09-09 2020-05-11
USD982545S1 (en) * 2020-01-30 2023-04-04 Mitsubishi Electric Corporation Servo amplifier
USD987594S1 (en) * 2020-04-21 2023-05-30 Mitsubishi Electric Corporation Servo amplifier

Also Published As

Publication number Publication date
USD1016033S1 (en) 2024-02-27
TWD217038S (zh) 2022-02-01

Similar Documents

Publication Publication Date Title
JP1696295S (Direct)
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134206A1 (es) Degradantes y usos de los mismos
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134176A1 (es) VARIANTES DEL DOMINIO Fc CON UNIÓN MEJORADA AL RECEPTOR Fc
AR134164A1 (es) Modificadores covalentes reversibles de lisina de cdk2 y usos de los mismos